New MRSA bill in Congress
The MRSA Infection Prevention and Patient Protection Act was recently introduced into both the US House of Representatives and Senate. The bill mandates testing for MRSA on admission and discharge from the ICU and other high risk units. We can only hope that CDC is able to influence the lawmakers by bringing MRSA into perspective. If not, the winners will be the companies who make the MRSA testing products. The losers will be hospital infection control programs, which are already overworked and underresourced, and the patients these programs serve.